Paragraph IV challenges have become routine for almost every major GLP-1 product shortly after they become eligible
And do not confuse Rybelsus, the oral diabetes-only tablet at roughly $998 a month, with the weight-loss-approved oral Wegovy pill
Accelerated Healing of Skin and Soft Tissue Injuries: BPC-157 promotes the healing of skin and soft tissue injuries, such as cuts, burns, and sprains
After the development of Zepbound and anticipated demand, the company expanded its manufacturing and quality control processes with distribution to retail and mail-order pharmacies
TA875 for semaglutide and TA664 for liraglutide in weight management), GLP-1 receptor agonists are recommended as part of a comprehensive treatment strategy that includes dietary modification, increased physical activity, and other glucose-lowering therapies when appropriate
FDA Combines All Adverse Event Reporting Systems into One Public Dashboard What is happening: FDA announced on March 11, 2026 that it is creating a single publicly accessible dashboard to allow stakeholders to search adverse events for all regulated products, accomplishing one of Commissioner Marty Makarys goals upon arriving at the agency last spring
